Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nitrile. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114436890B reveals a high-yield copper-catalyzed synthesis of 3-amino-2-indenecarbonitrile. Discover cost-effective manufacturing and supply chain advantages.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Cost-effective, scalable route for pharma intermediates.
Novel mild method for alpha-aryl nitriles using aryl sulfoxides and tin reagents. High yield, scalable process for reliable pharmaceutical intermediate supply chain.
Patent CN121159423A reveals mild nickel-catalyzed ketone nitrile synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN109694335B reveals a green, solvent-free route for nitrophenylacetonitrile derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110117237B reveals a mild nickel-catalyzed cyanation method for aromatic nitriles. This technology offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN110511175A reveals mild radical cyclization. Enables cost reduction in pharmaceutical intermediates manufacturing with high-purity pharmaceutical intermediates.
Patent CN108623496B reveals a safe, scalable route for 3-ethyl-4-fluorobenzonitrile, eliminating toxic tin reagents for cost-effective API manufacturing.
Patent CN113072470A reveals a mild Cu-catalyzed synthesis for N-acetonitrile bis-benzenesulfonylimine derivatives, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114456089B details a novel cobalt-catalyzed three-component reaction enabling efficient synthesis of amino-nitrile pharmaceutical intermediates with reduced costs.
Novel nickel-catalyzed method for ketone nitrile compounds reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing significantly
Patent CN105175370A reveals a novel palladium-catalyzed route for Olaparib intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Cost-effective, scalable route for pharma intermediates.
Patent CN118908853A reveals a safe copper-catalyzed route for high-purity acrylonitrile intermediates, offering significant supply chain and cost advantages.
Novel nickel-catalyzed method for ketone nitriles offers mild conditions and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Advanced patent-based synthesis for high-purity fluorine intermediates. Offers significant cost reduction in pharmaceutical manufacturing and reliable supply chain continuity.
Patent CN100418953C reveals a novel telmisartan synthesis route eliminating needle crystallization issues, ensuring high purity and cost reduction in pharmaceutical manufacturing.
Patent CN110590771B details an efficient 5-step synthesis of [1,5-a]-pyridoimidazole-1-carbonitrile from 2-fluoropyridine, offering cost reduction in API manufacturing and scalable production capabilities.
Patent CN117126077B reveals a green visible-light iron catalyzed route for 4-arylbutyronitrile. Achieve 100% atom economy and cost reduction in fine chemical manufacturing.
Novel isonitrile-based route for quinoline derivatives. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.